| Chair: Ana Patiño Clínica Universidad de Navarra y CIMA LAB Diagnostics, Universidad de Navarra, Pamplona, Spain Gorka Alkorta CIMA LAB Diagnostics, Universidad de Navarra, Pamplona, Spain |
|
| 15:30 - 16:00 | Molecular subtypes of colorectal cancer Rodrigo Dientsmann Vall d’Hebron University Hospital, Barcelona, Spain |
| 16:00 - 16:30 | Somatic mutation and clonal expansion in human tissues Iñigo Martincorena Sanger Institute, Cambridge, UK |
| 16:30 - 17:00 | Humanized mouse technologies for the study of human specific tumor microenvironment and immunotherapy Qingfeng Chen Institute of Molecular and Cell Biology, A*STAR, Singapore |
| 17:00 - 17:20 | Discussion |
| Chairs: José María López-Picazo Clínica Universidad de Navarra, Pamplona, Spain Mariano Ponz-Sarvisé Clínica Universidad de Navarra, Pamplona, Spain |
|
| 17:35 - 18:05 | Genomic testing in clinical trials Philippe Bedard Princess Margaret Cancer Centre, Toronto, Canada |
| 18:05 - 18:35 | Use of new targeted agents using genomic testing, NTRK as an example Elena Garralda Vall d’Hebron University Hospital, Barcelona, Spain |
| 18:35 - 19:05 | New Era in Pancreatic Cancer, germinal testing for patient’s treatment Teresa Macarulla Vall d’Hebron University Hospital, Barcelona, Spain |
| 19:05 - 19:35 | Genomic testing after progression to genomic testing, the MATCH R Trial Luc Friboulet DITEP, Gustave Roussy, Paris, France |
| 19:35 - 19:55 | Discussion |